Diabetes Monitoring Platform Glooko Snags Medtronic As an Investor, Lands $16.5 Million
Glooko, a digital health company that helps users unlock data from their glucose meter and wearables to better manage patients, has raised a Series B round led by Medtronic and Canaan Partners. The Social + Capital Partnership and Samsung’s venture investment arm also participated in the round. Glooko added Samsung as a strategic partner last year. Its app is compatible with several Samsung devices.